Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study. Article uri icon

Overview

publication date

  • May 21, 2013

Research

keywords

  • Imidazoles
  • Leukemia, Myeloid, Acute
  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Pyridazines
  • fms-Like Tyrosine Kinase 3

Identity

PubMed Central ID

  • PMC3866040

Scopus Document Identifier

  • 84880703294

Digital Object Identifier (DOI)

  • 10.1111/bjh.12382

PubMed ID

  • 23691988

Additional Document Info

volume

  • 162

issue

  • 4